Lifecore Biomedical, Inc. (LFCR) Q3 2027 Earnings — Miss Estimates

Screener

Reported May 6, 2026

Revenue$23.2MMiss by $2.8M

EPS-$0.43Miss by $0.14

Revenue estimate$26.0M

EPS estimate-$0.29

Next report

Date not yet announced

Versus estimates

Revenue

Q4 2027$34.2MIn line

Q3 2027$23.2MMiss by $2.8M

Q3 2026$35.2MBeat by $2.0M Q2 2026$31.1MBeat by $4.6M

Diluted EPS

Q4 2027-$0.19In line Q2 2027-$0.19Beat by $0.01

Q3 2027-$0.43Miss by $0.14

Q4 2026-$0.43Miss by $0.19 Q3 2026-$0.16Beat by $0.11 Q2 2026-$0.29Beat by $0.01

FAQ

When did Lifecore Biomedical, Inc. report Q3 2027 earnings?: Lifecore Biomedical, Inc. (LFCR) reported Q3 2027 earnings on May 6, 2026.
What were Lifecore Biomedical, Inc.'s Q3 2027 revenue and EPS?: Lifecore Biomedical, Inc. reported revenue of $23.2M and eps of $-0.43 for Q3 2027.
Did Lifecore Biomedical, Inc. beat estimates in Q3 2027?: Revenue missed the consensus estimate of $26.0M by $2.8M. EPS missed the consensus estimate of $-0.29 by $0.14.
Where can I find Lifecore Biomedical, Inc.'s Q3 2027 SEC filings?: You can read the 8-K earnings release (0001005286-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Lifecore Biomedical, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk